India to Turkey: Ibrutinib Export Trade Route
India has recorded 33 verified shipments of Ibrutinib exported to Turkey, representing a combined trade value of $41.5K USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $1.3K USD. The leading Indian exporter is ROYAL MEDICAL PRIVATE LIMITED, which accounts for 38% of total export value with 10 shipments worth $15.8K USD. On the buying side, TO THE ORDER OF INVOICE RAISED TO is the largest importer in Turkey with $15.5K USD in purchases. The top 3 suppliers — ROYAL MEDICAL PRIVATE LIMITED, RMPL PHARMA LLP, M T MADON EXPORTS — together control 63% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Turkey Ibrutinib corridor is one of India's established pharmaceutical export routes, with 33 shipments documented worth a combined $41.5K USD. The route is dominated by ROYAL MEDICAL PRIVATE LIMITED, which alone accounts for roughly 38% of all export value, reflecting the consolidated nature of India's ibrutinib manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $1.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with ibrutinib's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 18.5%, placing it at rank #19 among India's top ibrutinib export destinations globally.
On the import side, key buyers of Indian ibrutinib in Turkey include TO THE ORDER OF INVOICE RAISED TO, SLO TIBBI ILAC ITHALAT, TO THE ORDER OF INVOICE and 11 others. TO THE ORDER OF INVOICE RAISED TO is the single largest importer with 9 shipments valued at $15.5K USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ2
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#19
- Annual growth+18.5%
- Demand growth+15.9%
- Regulatory ease85/100
Top 10 Indian Ibrutinib Exporters to Turkey
Showing top 10 of 10 Indian suppliers exporting Ibrutinib to Turkey, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ROYAL MEDICAL PRIVATE LIMITED Avg $1.6K per shipment | 10 | $15.8K | 38.1% |
| 2 | RMPL PHARMA LLP Avg $754 per shipment | 7 | $5.3K | 12.7% |
| 3 | M T MADON EXPORTS Avg $1.7K per shipment | 3 | $5.0K | 12.1% |
| 4 | AMARI TRADE ALLIANCE LLP Avg $2.3K per shipment | 2 | $4.5K | 10.9% |
| 5 | RIZLIFE HEALTHCARE Avg $1.2K per shipment | 3 | $3.5K | 8.5% |
| 6 | RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED Avg $2.3K per shipment | 1 | $2.3K | 5.5% |
| 7 | ROYAL MEDICAL PRIVATE LIMITED Avg $444 per shipment | 4 | $1.8K | 4.3% |
| 8 | GENETEC LIFESCIENCES Avg $1.6K per shipment | 1 | $1.6K | 3.8% |
| 9 | ROYAL MEDICAL PVT LTD Avg $1.5K per shipment | 1 | $1.5K | 3.7% |
| 10 | RMPL PHARMA LLP Avg $207 per shipment | 1 | $207 | 0.5% |
This table shows the top 10 of 10 Indian companies exporting ibrutinib to Turkey, ranked by total trade value. The listed exporters are: ROYAL MEDICAL PRIVATE LIMITED, RMPL PHARMA LLP, M T MADON EXPORTS, AMARI TRADE ALLIANCE LLP, RIZLIFE HEALTHCARE , RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED, ROYAL MEDICAL PRIVATE LIMITED , GENETEC LIFESCIENCES, ROYAL MEDICAL PVT LTD, RMPL PHARMA LLP . ROYAL MEDICAL PRIVATE LIMITED is the dominant supplier with 10 shipments worth $15.8K USD, giving it a 38% market share. The top 3 suppliers together account for 63% of the total trade value on this route.
Top 10 Ibrutinib Importers in Turkey
Showing top 10 of 14 known buyers in Turkey receiving Ibrutinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ibrutinib in Turkey include TO THE ORDER OF INVOICE RAISED TO, SLO TIBBI ILAC ITHALAT, TO THE ORDER OF INVOICE, K.S. ATLAS DIS TIC.LTD STI , IMPORT PARTY CODE 1019, among 14 total buyers. The largest importer is TO THE ORDER OF INVOICE RAISED TO, accounting for $15.5K USD across 9 shipments — representing 37% of all ibrutinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TO THE ORDER OF INVOICE RAISED TO | 9 | $15.5K | 37.4% |
| 2 | SLO TIBBI ILAC ITHALAT | 2 | $4.4K | 10.7% |
| 3 | TO THE ORDER OF INVOICE | 3 | $3.6K | 8.6% |
| 4 | K.S. ATLAS DIS TIC.LTD STI | 3 | $3.5K | 8.5% |
| 5 | IMPORT PARTY CODE 1019 | 1 | $2.8K | 6.7% |
| 6 | AL HASEM OTOMOTIV TICARET LIMITED S | 1 | $2.3K | 5.5% |
| 7 | IMPORT PARTY CODE 1051 | 1 | $1.7K | 4.2% |
| 8 | . | 4 | $1.7K | 4.1% |
| 9 | TO THE ORDER OF | 1 | $1.6K | 3.8% |
| 10 | NA | 1 | $1.5K | 3.7% |
Showing top 10 of 14 Ibrutinib importers in Turkey on this route.
Top 10 Ibrutinib Formulations Imported by Turkey
Showing top 10 of 22 product formulations shipped on the India to Turkey Ibrutinib route, ranked by trade value
Turkey imports a wide range of ibrutinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — NITIB 140 MG (30CAP) (IBRUTINIB) — accounts for $10.7K USD across 3 shipments. There are 22 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NITIB 140 MG (30CAP) (IBRUTINIB) | 3 | $10.7K | 25.8% |
| 2 | NITIB 140 MG 30CAP IBRUTINIB | 5 | $4.2K | 10.0% |
| 3 | NITIB 140MG CAPSULE[150 NOS X 30 = 4500TAB ]EACH TAB CONT IBRUTINIB 140MGNOS | 1 | $3.8K | 9.1% |
| 4 | NITIB(IBRUTINIB CAPSULES 140 MG)BT NO.AC | 3 | $3.5K | 8.5% |
| 5 | MEDICINE FOR HUMAN USE IBRUTINIB CAPSULES 140MG HSN 30049099 PACK 30CAP BOTTLE BRAND NITIB 140MG CAP 50PACKSX30 1500CAP | 1 | $2.8K | 6.7% |
| 6 | NITIB 140 MG Ibrutinib Capsules 140 Mg | 1 | $2.3K | 5.5% |
| 7 | NITIB 140 MG (30CAP) (IBRUTINIB) | 4 | $1.8K | 4.3% |
| 8 | MEDICINE FOR HUMAN USE IBRUTINIB CAPSULES 140MG BRAND :- NITIB 140MG CAP (30PACK x1x30=900CAPS) | 1 | $1.7K | 4.2% |
| 9 | NITIB 140MG (30CAP) (IBRUTINIB CAPSULES)(30 PACKx30=900 CAPS) | 1 | $1.6K | 3.9% |
| 10 | MEDICINE FOR HUMAN USE IBRUTINIB CAPSULES 140MG HSN : 30049099 PACK : 30CAP BOTTLE BRAND :- NITIB 140MG CAP | 1 | $1.6K | 3.8% |
Showing top 10 of 22 Ibrutinib formulations imported by Turkey on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 81%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 12 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's ibrutinib exports to Turkey are driven primarily by a handful of large-scale manufacturers. ROYAL MEDICAL PRIVATE LIMITED with 10 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in Turkey benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ROYAL MEDICAL PRIVATE LIMITED, RMPL PHARMA LLP, M T MADON EXPORTS — together account for 63% of total trade value on this route. The average shipment value of $1.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as nitib 140 mg 30cap ibrutinib and nitib 140mg capsule[150 nos x 30 = 4500tab ]each tab cont ibrutinib 140mgnos, suggesting that buyers in Turkey tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TO THE ORDER OF INVOICE RAISED TO is the largest importer with 9 shipments worth $15.5K USD — representing 37% of all ibrutinib imports from India on this route. A total of 14 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $41.5K
- Avg. Shipment
- $1.3K
- Suppliers
- 10
- Buyers
- 14
- Transit (Sea)
- ~17 days
- Annual Growth
- +18.5%
Reverse Direction
Turkey → India — Ibrutinib (Import)Other Ibrutinib Routes
Unlock the Full India to Turkey Ibrutinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 33 shipments on this route.
Frequently Asked Questions — India to Turkey Ibrutinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ibrutinib to Turkey?
The leading Indian exporters of Ibrutinib to Turkey are ROYAL MEDICAL PRIVATE LIMITED, RMPL PHARMA LLP, M T MADON EXPORTS. ROYAL MEDICAL PRIVATE LIMITED holds the largest market share at approximately 38% of total trade value on this route.
Q What is the total value of Ibrutinib exports from India to Turkey?
India exports Ibrutinib to Turkey worth approximately $41.5K USD across 33 recorded shipments. The average value per shipment is $1.3K USD.
Q Which ports does India use to ship Ibrutinib to Turkey?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 12 shipments. Indian exporters primarily use sea freight for this route, with 81% of shipments going by sea and 27% by air.
Q How long does shipping take from India to Turkey for Ibrutinib?
The average transit time for Ibrutinib shipments from India to Turkey is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Turkey Ibrutinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 18.5% with demand growth tracking at 15.9%. The route is ranked #19 among India's top Ibrutinib export destinations globally.
Q How many suppliers are active on the India to Turkey Ibrutinib route?
There are currently 10 active Indian suppliers exporting Ibrutinib to Turkey. The market is moderately concentrated with ROYAL MEDICAL PRIVATE LIMITED accounting for 38% of total shipment value.
Q Who are the main importers of Ibrutinib from India in Turkey?
The leading importers of Indian Ibrutinib in Turkey include TO THE ORDER OF INVOICE RAISED TO, SLO TIBBI ILAC ITHALAT, TO THE ORDER OF INVOICE, K.S. ATLAS DIS TIC.LTD STI , IMPORT PARTY CODE 1019. TO THE ORDER OF INVOICE RAISED TO is the largest buyer with 9 shipments worth $15.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Turkey export trade corridor identified from Indian Customs (DGFT) records for Ibrutinib.
- 2.Supplier/Buyer Matching: 10 Indian exporters and 14 importers in Turkey matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 33 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
33 Verified Shipments
10 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists